The leader in quality education and networking through//conferences, courses and custom training
Connect with IBC Life Sciences:LinkedIn iconTwitter iconFacebook iconRSS icon
EmailPrint
Biopharmaceutical Development & Production Week

Registration

Save $100 if you register by February 3.
» View Pricing

Download Brochure

Add to Outlook Calendar

Find Another IBC Event

Recombinant Protein & Complex Biologic Development & Production

CSS

Alternate Language Options:

  • Japanese
  • Korean
  • Taiwanese
  • Chinese
  • English

Approaches to Overcome the Unique Technical and Scientific Challenges of Developing Novel Molecules

February 29 - March 02, 2012 · Hilton San Diego Bayfront Hotel · San Diego, CA

Event Overview

Event Overview

The Recombinant Protein & Complex Biologic Development & Production conference covers the entire spectrum of topics related to improving the efficiency of developing and producing next generation and novel molecules. Companies are now looking "beyond antibodies" to new formats for making better drugs which has dramatically expanded the scope of novel molecules. This event is designed to bring together industry experts representing companies of all sizes to share successful approaches that can help you overcome the unique technical and scientific challenges in upstream and downstream processing.

This Conference Will Help You:

  • Expanded coverage of the critical achievements to overcome the challenges of development, scale up and characterization of novel molecules
  • Gain insights from companies implementing disruptive technologies and innovative process solutions to improve speed and cost of development

The Agenda Covers these Critical Topics:

  • Successful and alternative approaches to scaling up complex biologics
  • Improve speed and reduce cost of upstream and downstream process development
  • Explore the disruptive technologies that are causing paradigm shifts in upstream and downstream processing
  • Leveraging innovation for more efficient development and manufacturing of protein drugs and biobetters
  • Effective development of novel proteins with increased half-life and bioavailability
  • Approaches to increase molecular understanding and the impact on industrial production
  • Developing novel proteins that fit into a platform-based downstream purification process
  • Compare the latest analytical

Find Out How the Industry is Addressing these Critical Topics

Anthony S. Lubiniecki, Sc.D.

Comparability Within A Single Product Differs from Biosimilarity Between Two Products
Anthony S. Lubiniecki, Sc.D.
Johnson & Johnson Pharmaceutical R&D, Inc.

Morris Rosenberg, Ph.D.

Path to Approval for Antibody Drug Conjugates
Morris Rosenberg, D.Sc.
Seattle Genetics

Bill Strohl, Ph.D.

The Challenge of Discovery and Developing Biobetters - They Had Better Be Better!
Bill Strohl, Ph.D.
Centocor R&D

James Swartz, D.Sc., M.S.

Cell-Free Production of Complex Proteins and Protein Complexes
James R. Swartz, D.Sc., M.S.
Stanford University

Jens H. Vogel, Ph.D.

Leveraging Innovation for More Efficient Development and Manufacturing of Protein Drugs and Biobetters
Jens H. Vogel, Ph.D.
Bayer Healthcare

Special thanks to the Scientific Advisory Committee for their help in developing this program.
» View the list of committee members